Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
16.9%
% of WDNA's 91 holdings also in PBE
53.6%
% of PBE's 28 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in PBE |
Overlap | |
---|---|---|---|---|
BLUEPRINT MEDICINES CORP. | 2.2% | 2.8% | 2.2% | |
VERICEL CORPORATION | 1.7% | 2.9% | 1.7% | |
AMICUS THERAPEUTICS INC | 1.4% | 2.4% | 1.4% | |
VERTEX PHARMACEUTICALS INC | 1.3% | 4.9% | 1.3% | |
REPLIGEN CORP | 1.2% | 2.4% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to PBE
IOVANCE BIOTHERAPEUTICS INC | 3.9% | |
TWIST BIOSCIENCE CORP. | 3.4% | |
FATE THERAPEUTICS INC | 3.1% | |
NOVOZYMES A/S-B SHARES | 2.4% | |
BRIDGEBIO PHARMA, INC. | 2.0% | |
NATERA INC | 1.9% | |
ELI LILLY & CO | 1.9% | |
CRISPR THERAPEUTICS AG | 1.8% | |
ALCOBRA LTD | 1.7% | |
AGIOS PHARMACEUTICALS INC | 1.6% |
WDNA Underweight Relative to PBE
NEUROCRINE BIOSCIENCES INC | -5.3% | |
BIOMARIN PHARMACEUTICAL INC | -4.0% | |
GILEAD SCIENCES INC | -4.0% | |
BIOGEN IDEC INC | -3.9% | |
BIO-TECHNE CORPORATION | -3.9% | |
REGENERON PHARMACEUTICALS | -3.9% | |
AMGEN INC | -3.7% | |
VERTEX PHARMACEUTICALS INC | -3.6% | |
COLLEGIUM PHARMACEUTICAL, INC. | -3.5% | |
HALOZYME THERAPEUTICS INC | -3.2% |